LOURDES TORRES: Open Payments
NPI 1508208174 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,157 in 79 payments from 12 companies in 2025. Trend: 2023 $1,841 · 2024 $1,186 · 2025 $2,157
Food & beverage: $2,157
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 15 | $557 |
| ACADIA Pharmaceuticals Inc | 21 | $305 |
| Janssen Pharmaceuticals, Inc | 7 | $255 |
| Otsuka America Pharmaceutical, Inc. | 6 | $255 |
| Vanda Pharmaceuticals Inc. | 4 | $177 |
| Lundbeck LLC | 8 | $171 |
| Alkermes, Inc. | 7 | $129 |
| Alpha Cognition USA, Inc. | 3 | $81 |
| LivaNova USA, Inc. | 1 | $79 |
| Teva Pharmaceuticals USA, Inc. | 3 | $64 |
Products named: INGREZZA, REXULTI, NUPLAZID, INVEGA SUSTENNA, FANAPT, ARISTADA, Zunveyl, VNS THERAPY SYMMETRY MODEL 8103 GENERATOR.
Industry payments across LA — which companies pay providers there.
